Preliminary findings of a randomized trial of non-pharmaceutical interventions to prevent influenza transmission in households

Benjamin J Cowling, Rita O P Fung, Calvin K Y Cheng, Vicky J Fang, Kwok Hung Chan, Wing Hong Seto, Raymond Yung, Billy Chiu, Paco Lee, Timothy M Uyeki, Peter M Houck, J S Malik Peiris, Gabriel M Leung, Benjamin J Cowling, Rita O P Fung, Calvin K Y Cheng, Vicky J Fang, Kwok Hung Chan, Wing Hong Seto, Raymond Yung, Billy Chiu, Paco Lee, Timothy M Uyeki, Peter M Houck, J S Malik Peiris, Gabriel M Leung

Abstract

Background: There are sparse data on whether non-pharmaceutical interventions can reduce the spread of influenza. We implemented a study of the feasibility and efficacy of face masks and hand hygiene to reduce influenza transmission among Hong Kong household members.

Methodology/principal findings: We conducted a cluster randomized controlled trial of households (composed of at least 3 members) where an index subject presented with influenza-like-illness of <48 hours duration. After influenza was confirmed in an index case by the QuickVue Influenza A+B rapid test, the household of the index subject was randomized to 1) control or 2) surgical face masks or 3) hand hygiene. Households were visited within 36 hours, and 3, 6 and 9 days later. Nose and throat swabs were collected from index subjects and all household contacts at each home visit and tested by viral culture. The primary outcome measure was laboratory culture confirmed influenza in a household contact; the secondary outcome was clinically diagnosed influenza (by self-reported symptoms). We randomized 198 households and completed follow up home visits in 128; the index cases in 122 of those households had laboratory-confirmed influenza. There were 21 household contacts with laboratory confirmed influenza corresponding to a secondary attack ratio of 6%. Clinical secondary attack ratios varied from 5% to 18% depending on case definitions. The laboratory-based or clinical secondary attack ratios did not significantly differ across the intervention arms. Adherence to interventions was variable.

Conclusions/significance: The secondary attack ratios were lower than anticipated, and lower than reported in other countries, perhaps due to differing patterns of susceptibility, lack of significant antigenic drift in circulating influenza virus strains recently, and/or issues related to the symptomatic recruitment design. Lessons learnt from this pilot have informed changes for the main study in 2008.

Trial registration: ClinicalTrials.gov NCT00425893 HKClinicalTrials.com HKCTR-365.

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1. Flow of subjects through the…
Figure 1. Flow of subjects through the study.
Figure 2. Delays between index case symptom…
Figure 2. Delays between index case symptom onset, randomization, and intervention in 128 households.
Time intervals a) from symptom onset in the index subject to randomization; b) from randomization to application of the intervention; c) from symptom onset to application of the intervention.

References

    1. Proença-Módena JL, Macedo IS, Arruda E. H5N1 avian influenza virus: an overview. Braz J Infect Dis. 2007;11:125–133.
    1. Beigel JH, Farrar J, Han AM, Hayden FG, Hyer R, et al. Avian influenza A (H5N1) infection in humans. N Engl J Med. 2005;353:1374–1385.
    1. Ungchusak K, Auewarakul P, Dowell SF, Kitphati R, Auwanit W, et al. Probable person-to-person transmission of avian influenza A (H5N1). N Engl J Med. 2005;352:333–340.
    1. Kandun IN, Wibisono H, Sedyaningsih ER, Yusharmen, Hadisoedarsuno W, et al. Three Indonesian clusters of H5N1 virus infection in 2005. N Engl J Med. 2006;355:2186–2194.
    1. Stohr K, Esveld M. Public health. Will vaccines be available for the next influenza pandemic? Science. 2004;306:2195–2196.
    1. Lipsitch M, Cohen T, Murray M, Levin BR. Antiviral Resistance and the Control of Pandemic Influenza. PLoS Medicine. 2007;4:e15.
    1. Aledort JE, Lurie N, Wasserman J, Bozzette SA. Non-pharmaceutical public health interventions for pandemic influenza: an evaluation of the evidence base. BMC Public Health. 2007;7:208.
    1. Aiello AE, Coulborn R, Perez V, Larson EL. Effect of Hand Hygiene on Infectious Disease Risk in the Community Setting: A Meta-Analysis. Am J Public Health (in press) 2008
    1. Jefferson T, Foxlee R, Mar CD, Dooley L, Ferroni E, et al. Physical interventions to interrupt or reduce the spread of respiratory viruses: systematic review. BMJ. 2008;336:77–80.
    1. Epstein JM, Goedecke DM, Yu F, Morris RJ, Wagener DK, et al. Controlling Pandemic Flu: The Value of International Air Travel Restrictions. PLoS ONE. 2007;2:e401.
    1. World Health Organization (WHO) Writing Group. Nonpharmaceutical Interventions for Pandemic Influenza, International Measures. Emerg Infect Dis. 2006;12:81–87.
    1. World Health Organization (WHO) Writing Group. Nonpharmaceutical Interventions for Pandemic Influenza, National and Community Measures. Emerg Infect Dis. 2006;12:88–94.
    1. Wong CM, Chan KP, Hedley AJ, Peiris JS. Influenza-associated mortality in Hong Kong. Clin Infect Dis. 2004;39:1611–1617.
    1. Monto AS. Individual and community impact of influenza. Pharmacoeconomics 16 Suppl. 1999;1:1–6.
    1. Molinari NA, Ortega-Sanchez IR, Messonnier ML, Thompson WW, Wortley PM, et al. The annual impact of seasonal influenza in the US: measuring disease burden and costs. Vaccine. 2007;25:5086–5096.
    1. Campbell MK, Elbourne DR, Altman DG, group C. CONSORT statement: extension to cluster randomised trials. BMJ. 2004;328:702–708.
    1. World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2000;284:3043–3045.
    1. Larson EL. APIC guideline for handwashing and hand antisepsis in health care settings. Am J Infect Control. 1995;23:251–269.
    1. Monto AS, Pichichero ME, Blanckenberg SJ, Ruuskanen O, Cooper C, et al. Zanamivir prophylaxis: an effective strategy for the prevention of influenza types A and B within households. J Infect Dis. 2002;186:1582–1588.
    1. Babcock HM, Merz LR, Fraser VJ. Is influenza an influenza-like illness? Clinical presentation of influenza in hospitalized patients. Infect Control Hosp Epidemiol. 2006;27:266–270.
    1. Viboud C, Boelle PY, Cauchemez S, Lavenu A, Valleron AJ, et al. Risk factors of influenza transmission in households. Br J Gen Pract. 2004;54:684–689.
    1. Donner A, Klar N. Design and analysis of cluster randomization trials in health research. London: Arnold; 2000.
    1. Liang K-Y, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika. 1986;73:13–22.
    1. Pepe MS. The Statistical Evaluation of Medical Tests for Classification and Prediction. New York: Oxford University Press; 2003.
    1. R Development Core Team. R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2004.
    1. Tellier R. Review of aerosol transmission of influenza A virus. Emerg Infect Dis. 2006;12:1657–1662.
    1. Jefferson T, Foxlee R, Mar CD, Dooley L, Ferroni E, et al. Physical interventions to interrupt or reduce the spread of respiratory viruses: systematic review. BMJ (in press) 2007
    1. Lo JY. Respiratory Infections during SARS Outbreak, Hong Kong, 2003. Emerg Infect Dis. 2005;11:1738–1741.
    1. Leung GM, Ho LM, Chan SK, Ho SY, Bacon-Shone J, et al. Longitudinal assessment of community psychobehavioral responses during and after the 2003 outbreak of severe acute respiratory syndrome in Hong Kong. Clin Infect Dis. 2005;40:1713–1720.
    1. Sandora TJ, Taveras EM, Shih MC, Resnick EA, Lee GM, et al. A randomized, controlled trial of a multifaceted intervention including alcohol-based hand sanitizer and hand-hygiene education to reduce illness transmission in the home. Pediatrics. 2005;116:587–594.
    1. Fox JP. Viruses in families. Littleton, Mass.: PSG Pub. Co; 1980.
    1. King JC, Jr., Stoddard JJ, Gaglani MJ, Moore KA, Magder L, et al. Effectiveness of school-based influenza vaccination. N Engl J Med. 2006;355:2523–2532.
    1. Monto AS, Gravenstein S, Elliott M, Colopy M, Schweinle J. Clinical signs and symptoms predicting influenza infection. Arch Intern Med. 2000;160:3243–3247.
    1. Zambon M, Hays J, Webster A, Newman R, Keene O. Diagnosis of influenza in the community: relationship of clinical diagnosis to confirmed virological, serologic, or molecular detection of influenza. Arch Intern Med. 2001;161:2116–2122.
    1. Friedman MJ, Attia MW. Clinical predictors of influenza in children. Arch Pediatr Adolesc Med. 2004;158:391–394.
    1. Ohmit SE, Monto AS. Symptomatic predictors of influenza virus positivity in children during the influenza season. Clin Infect Dis. 2006;43:564–568.
    1. Carrat F, Tachet A, Rouzioux C, Housset B, Valleron AJ. Evaluation of clinical case definitions of influenza: detailed investigation of patients during the 1995–1996 epidemic in France. Clin Infect Dis. 1999;28:283–290.
    1. Call SA, Vollenweider MA, Hornung CA, Simel DL, McKinney WP. Does this patient have influenza? JAMA. 2005;293:987–997.
    1. Uyeki TM. Influenza diagnosis and treatment in children: a review of studies on clinically useful tests and antiviral treatment for influenza. Pediatr Infect Dis J. 2003;22:164–177.
    1. Morse SS, Garwin RL, Olsiewski PJ. Public health. Next flu pandemic: what to do until the vaccine arrives? Science. 2006;314:929.

Source: PubMed

3
Abonneren